LXEO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Lexeo Therapeutics, Inc. Common Stock

NASDAQ | LXEO

8.38

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$607.26M

Market Cap

-

P/E Ratio

-2.33

EPS

$10.38

52 Week High

$1.45

52 Week Low

HEALTHCARE

Sector

LXEO Chart

Recent Chart
Price Action

LXEO Technicals

Tags:

LXEO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$2M
Total Revenue $0
Cost Of Revenue $2M
Costof Goods And Services Sold $2M
Operating Income -$106M
Selling General And Administrative $32M
Research And Development $74M
Operating Expenses $106M
Investment Income Net -
Net Interest Income $7.4M
Interest Income $7.6M
Interest Expense $114K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2M
Income Before Tax -$98M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$98M
Comprehensive Income Net Of Tax -
Ebit -$98M
Ebitda -$96M
Net Income -$98M

Revenue & Profitability

Earnings Performance

LXEO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $147M
Total Current Assets $126M
Cash And Cash Equivalents At Carrying Value $35M
Cash And Short Term Investments $35M
Inventory -
Current Net Receivables -
Total Non Current Assets $21M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $7M
Short Term Investments $87M
Other Current Assets $4.6M
Other Non Current Assets -
Total Liabilities $30M
Total Current Liabilities $23M
Current Accounts Payable $6.4M
Deferred Revenue -
Current Debt -
Short Term Debt $2.7M
Total Non Current Liabilities $7.3M
Capital Lease Obligations $9.9M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $9.9M
Other Current Liabilities $14M
Other Non Current Liabilities -
Total Shareholder Equity $117M
Treasury Stock -
Retained Earnings -$280M
Common Stock $3K
Common Stock Shares Outstanding $32M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$81M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2M
Capital Expenditures $481K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$94M
Cashflow From Financing $89M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$17K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$98M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$2M
Total Revenue $0
Cost Of Revenue $2M
Costof Goods And Services Sold $2M
Operating Income -$106M
Selling General And Administrative $32M
Research And Development $74M
Operating Expenses $106M
Investment Income Net -
Net Interest Income $7.4M
Interest Income $7.6M
Interest Expense $114K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2M
Income Before Tax -$98M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$98M
Comprehensive Income Net Of Tax -
Ebit -$98M
Ebitda -$96M
Net Income -$98M

LXEO News

LXEO Profile

Lexeo Therapeutics, Inc. Common Stock Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Lexeo Therapeutics, Inc. is a New York-based clinical-stage genetic medicine company dedicated to developing pioneering therapies for hereditary and acquired diseases. Leveraging advanced gene-editing technologies, Lexeo is advancing a robust and diverse pipeline of innovative treatments aimed at addressing significant unmet medical needs and enhancing patient outcomes. With a strong commitment to proprietary platform development, Lexeo is well-positioned to make a substantial impact in the burgeoning field of genetic medicine, representing a compelling opportunity for institutional investors interested in transformative healthcare solutions.

LPTX
+368.57%
$2.05
PAVS
-38.29%
$0.03
VRAX
+49.12%
$0.58
IXHL
+16.01%
$0.46
IRBT
+63.24%
$3.18
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
NVDA
-0.47%
$180.60
IPG
-1.95%
$24.57
ONDS
-5.20%
$7.64
AXDX
-61.36%
$0.03
NIO
-5.66%
$4.74
KITT
+53.62%
$1.11
PLUG
+4.02%
$2.19
TSLA
+2.97%
$442.03
ADAP
-15.14%
$0.05
ASST
-2.41%
$1.01
BYND
-6.58%
$1.20
RR
+11.93%
$3.98
INTC
-0.07%
$43.43
IREN
+7.36%
$44.15
CAPR
+385.06%
$30.85
QCLS
+39.56%
$4.71
BITF
-2.74%
$3.01
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
INHD
-7.67%
$0.13
SRM
+53.27%
$10.30
RIVN
+0.40%
$17.23
AAL
+1.79%
$14.49
MRVL
+3.97%
$96.58
NFLX
-5.40%
$103.43
BMNU
+7.56%
$7.89
T
-1.04%
$25.52
BMNR
+3.63%
$33.07
VALE
+1.57%
$12.89
WLGS
-5.57%
$0.04
SOFI
+0.44%
$29.64
PFE
+1.92%
$25.63
MTSR
-0.35%
$70.50
PCG
-3.28%
$15.32
BBD
-2.22%
$3.58
HOOD
+2.19%
$125.95
F
+1.19%
$13.11
DNN
+1.73%
$2.63
AFMD
-34.94%
$0.18
ACHR
+4.37%
$7.98
MARA
+2.97%
$12.26
IMRN
-11.89%
$1.53
AAPL
-0.22%
$285.55
PMAX
+23.73%
$2.80
CIFR
+4.00%
$18.34
HTOO
+8.85%
$3.81
ASBP
-10.91%
$0.08
WULF
+1.51%
$14.43
MSFT
-1.60%
$482.11
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
CHR
-6.26%
$0.04
MODV
-25.22%
$0.43
QBTS
+2.12%
$22.97
CMND
-13.27%
$0.11
AMZN
-0.93%
$232.23
CCL
-0.34%
$25.84
AMD
+0.13%
$215.53
GOOGL
+1.35%
$320.08
PLTD
-1.79%
$6.83
KVUE
-0.17%
$16.83
JOBY
+2.67%
$13.83
PLTR
+1.93%
$173.99
AEO
-1.97%
$20.83
PLTZ
-3.85%
$6.99
PYPL
-2.46%
$61.35
CLSK
+0.83%
$13.82
AKTX
-14.10%
$0.34
BTBT
+1.33%
$2.26
BTG
+0.81%
$4.46
MSTR
+2.68%
$186.20
RIG
+3.68%
$4.46
VIVK
-12.15%
$0.09
KDLY
-2.95%
$0.48
CMG
-0.29%
$34.14
DVLT
-4.79%
$1.78
BAC
+1.52%
$54.00
CSCO
+1.09%
$76.87
SAND
-6.04%
$12.12
PSTG
-26.52%
$69.59
M
+2.04%
$23.17
SHOT
-74.37%
$0.39
YGMZ
-14.61%
$0.07
CRCL
+9.63%
$84.90
ZAPP
-46.30%
$0.15
BMY
+5.39%
$50.85
KXIN
+28.38%
$3.98
CAN
-1.36%
$0.95
KOS
-3.60%
$1.07
NOK
+0.48%
$6.22
LPTX
+368.57%
$2.05
PAVS
-38.29%
$0.03
VRAX
+49.12%
$0.58
IXHL
+16.01%
$0.46
IRBT
+63.24%
$3.18
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
NVDA
-0.47%
$180.60
IPG
-1.95%
$24.57
ONDS
-5.20%
$7.64
AXDX
-61.36%
$0.03
NIO
-5.66%
$4.74
KITT
+53.62%
$1.11
PLUG
+4.02%
$2.19
TSLA
+2.97%
$442.03
ADAP
-15.14%
$0.05
ASST
-2.41%
$1.01
BYND
-6.58%
$1.20
RR
+11.93%
$3.98
INTC
-0.07%
$43.43
IREN
+7.36%
$44.15
CAPR
+385.06%
$30.85
QCLS
+39.56%
$4.71
BITF
-2.74%
$3.01
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
INHD
-7.67%
$0.13
SRM
+53.27%
$10.30
RIVN
+0.40%
$17.23
AAL
+1.79%
$14.49
MRVL
+3.97%
$96.58
NFLX
-5.40%
$103.43
BMNU
+7.56%
$7.89
T
-1.04%
$25.52
BMNR
+3.63%
$33.07
VALE
+1.57%
$12.89
WLGS
-5.57%
$0.04
SOFI
+0.44%
$29.64
PFE
+1.92%
$25.63
MTSR
-0.35%
$70.50
PCG
-3.28%
$15.32
BBD
-2.22%
$3.58
HOOD
+2.19%
$125.95
F
+1.19%
$13.11
DNN
+1.73%
$2.63
AFMD
-34.94%
$0.18
ACHR
+4.37%
$7.98
MARA
+2.97%
$12.26
IMRN
-11.89%
$1.53
AAPL
-0.22%
$285.55
PMAX
+23.73%
$2.80
CIFR
+4.00%
$18.34
HTOO
+8.85%
$3.81
ASBP
-10.91%
$0.08
WULF
+1.51%
$14.43
MSFT
-1.60%
$482.11
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
CHR
-6.26%
$0.04
MODV
-25.22%
$0.43
QBTS
+2.12%
$22.97
CMND
-13.27%
$0.11
AMZN
-0.93%
$232.23
CCL
-0.34%
$25.84
AMD
+0.13%
$215.53
GOOGL
+1.35%
$320.08
PLTD
-1.79%
$6.83
KVUE
-0.17%
$16.83
JOBY
+2.67%
$13.83
PLTR
+1.93%
$173.99
AEO
-1.97%
$20.83
PLTZ
-3.85%
$6.99
PYPL
-2.46%
$61.35
CLSK
+0.83%
$13.82
AKTX
-14.10%
$0.34
BTBT
+1.33%
$2.26
BTG
+0.81%
$4.46
MSTR
+2.68%
$186.20
RIG
+3.68%
$4.46
VIVK
-12.15%
$0.09
KDLY
-2.95%
$0.48
CMG
-0.29%
$34.14
DVLT
-4.79%
$1.78
BAC
+1.52%
$54.00
CSCO
+1.09%
$76.87
SAND
-6.04%
$12.12
PSTG
-26.52%
$69.59
M
+2.04%
$23.17
SHOT
-74.37%
$0.39
YGMZ
-14.61%
$0.07
CRCL
+9.63%
$84.90
ZAPP
-46.30%
$0.15
BMY
+5.39%
$50.85
KXIN
+28.38%
$3.98
CAN
-1.36%
$0.95
KOS
-3.60%
$1.07
NOK
+0.48%
$6.22
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.